Video

Dr David R. Nunley on Re-Categorizing Lung Allograft Dysfunction

The categorization of lung allograft dysfunction is changing, David Nunley, MD, clinical director of lung transplant at the University of Louisville Health Care Outpatient Center, said at the 2014 CHEST meeting in Austin, Texas.

The categorization of lung allograft dysfunction is changing, David Nunley, MD, clinical director of lung transplant at the University of Louisville Health Care Outpatient Center, said at the 2014 CHEST meeting in Austin, Texas.

For a long time the industry spoke in terms of bronchiolitis obliterans syndrome, but now providers recognize that as just one small part of allograft dysfunction and some patients no longer fit into the category, he explained.

“We’re just now re-categorizing this, but this has long-term implications for how we’re going to treat these syndromes over the coming years,” Dr Nunley said.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Saad Z. Usmani, MD, MBA, FACP, FASCO, Memorial Sloan Kettering Cancer Center
EHA 2025 Congress Recap | Image Credit: Venngage
Lorna Warwick
Ashley Yocum, PhD
Dr Matthew Matasar
Dr Xavier Leleu
Francesco Sparano, MSc
Dr Marina Kremskayana
Dr Sundar Jagannath
Marla Black Morgan, MD, Phoebe Neurology Associates
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo